Skip to main content

Q&A: New Preprint Server for Clinical Research

The cofounder of bioRxiv, Richard Sever, discusses why there’s a need for the preprint server medRxiv that launched today.

Written byChia-Yi Hou
| 4 min read
Richard Sever bioRxiv medRxiv preprint server launch

Register for free to listen to this article
Listen with Speechify
0:00
4:00

Today (June 5), Cold Spring Harbor Laboratory, Yale University, and The BMJ are launching medRxiv, a preprint server for clinical research. It joins the likes of bioRxiv for basic biology and arXiv for math and physics, although medRxiv will have more stringent requirements for manuscripts. Authors will be asked to provide competing interests, all relevant ethical guidelines, clinical trial IDs, and other detailed information.

Richard Sever of Cold Spring Harbor Labortory is a cofounder of medRxiv and its predecessor bioRxiv, which was launched in 2013. The Scientist spoke to Sever about the launch of medRxiv.

The Scientist: What is the need for preprint servers?

Richard Sever: In general, there are a number of reasons. I think first and foremost it is speeding up dissemination of research. If you submit a paper to a journal, it takes on average about seven months before the work is actually published. But that’s an ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related Topics

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems
Optimizing NGS Library Preparation for Reliable Sequencing Data

Optimizing NGS Library Preparation for Reliable Sequencing Data

Covaris
Using TCR Repertoire Sequencing to Advance Immunology Research

Using TCR Repertoire Sequencing to Advance Immunology Research

Miltenyi

Products

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo
Conceptual image of ice and frost.

The VAULT100 PRO: Inside the most advanced Stirling Ultracold ULT freezer ever built.

Stirling Ultracold logo